# US Compression Therapy Market

> US Compression Therapy Market Research Report: Size, Share, Trend Analysis By End Users (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Rehabilitation Centers) By Applications (Chronic Venous Insufficiency, Lymphedema, Sports Injuries, Post-Surgical Recovery) By Product Type (Compression Garments, Compression Bandages, Compression Pumps, Compression Hosiery) By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Medical Supply Stores) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.42%
- **2024:** $ 819.11 Million
- **2025:** $ 863.51 Million
- **2035:** $ 1,463.89 Million
- **Key Players:** Medi USA (US), Sigvaris (CH), BSN Medical (DE), 3M (US), Juzo (DE), Lohmann & Rauscher (DE), Tactile Medical (US), Compression Therapy (US), Venosan (CH)

**Report ID:** MRFR/HC/16526-CR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** January 29, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-compression-therapy-market-18054

---

## Market Summary

## **US Compression Therapy Market Highlighted Trends & Dynamics**

The demand for compression therapy in the US is witnessing a notable surge, primarily attributed to the increasing prevalence of chronic conditions such as venous disorders, lymphedema, and deep vein thrombosis. Compression therapy serves as a non-invasive and effective approach to managing these conditions, contributing to its growing adoption.

**Aging Population and Vascular Health Concerns:** With the aging population in the US, there is a heightened focus on vascular health. Age-related issues, including venous insufficiency and circulation problems, drive the demand for compression therapy solutions. The elderly population seeks these therapies to alleviate symptoms, promote blood circulation, and enhance overall vascular well-being.

**Post-Surgery Recovery and Rehabilitation:** Compression therapy plays a crucial role in post-surgery recovery and rehabilitation. Surgeons and healthcare professionals recommend compression garments to aid in reducing swelling, preventing blood clots, and promoting faster healing following surgical procedures. This application contributes significantly to the demand for compression therapy products.

**Sports and Active Lifestyle Trends:** The increasing participation in sports and fitness activities in the US has led to a growing demand for compression wear among athletes. Compression garments are valued for their ability to improve blood flow, reduce muscle soreness, and enhance recovery post-exercise, catering to the needs of individuals engaged in various physical activities.

**Diabetes Management:** Diabetes, a prevalent chronic condition in the US, often comes with complications such as diabetic neuropathy and poor circulation. Compression therapy helps manage these complications by promoting better blood flow and reducing the risk of related issues, making it an essential component in the comprehensive care of individuals with diabetes.

**Wound Care and Edema Management:** Compression therapy is widely employed in wound care and edema management. The application of compression garments aids in reducing edema, improving tissue oxygenation, and facilitating the healing process for individuals with chronic wounds. This therapeutic approach is gaining traction within the healthcare community.

**Innovations in Compression Garment Design:** Ongoing innovations in the design and technology of compression garments contribute to the market's growth. Manufacturers are developing products that are not only effective in providing therapeutic benefits but also comfortable, aesthetically appealing, and suitable for everyday wear. This focus on design innovation enhances the overall patient experience and adherence to compression therapy.

**Patient Education and Awareness Initiatives:** Increased patient education and awareness initiatives contribute to the demand for compression therapy. Healthcare professionals actively educate patients about the benefits of compression garments, fostering a better understanding of their role in managing various medical conditions and encouraging patients to incorporate them into their treatment plans.

**Telemedicine and Remote Monitoring:** The integration of telemedicine and remote monitoring technologies has facilitated the adoption of compression therapy. Healthcare providers can remotely monitor patients' conditions, prescribe compression garments, and provide guidance on their proper use. This has expanded access to compression therapy, especially in remote or underserved areas.

**Healthcare Cost Containment:**

 As the US healthcare system continues to focus on cost containment and value-based care, compression therapy emerges as a cost-effective solution for managing certain medical conditions. By preventing complications, reducing hospital readmissions, and improving overall patient outcomes, compression therapy aligns with the healthcare industry's goal of delivering efficient and economically sustainable care.

## Market Drivers

### Rising Healthcare Expenditure

The increasing healthcare expenditure in the US is a significant driver for the compression therapy market. With healthcare spending projected to reach $6 trillion by 2027, there is a growing focus on preventive care and management of chronic conditions. Compression therapy is often viewed as a cost-effective intervention that can reduce the need for more invasive procedures, thereby appealing to both patients and healthcare providers. The emphasis on value-based care is likely to encourage the adoption of compression therapy as a standard treatment option for various conditions. This trend indicates that as healthcare budgets expand, there will be more resources allocated to therapies that improve patient quality of life, further propelling the compression therapy market.

### Advancements in Compression Technology

Innovations in compression technology are transforming the compression therapy market. The introduction of smart textiles and wearable devices that monitor patient compliance and provide real-time feedback is gaining traction. These advancements not only improve patient outcomes but also enhance the overall effectiveness of compression therapy. For instance, the integration of sensors in compression garments allows for personalized treatment plans, which can lead to better adherence and improved results. The market for these advanced products is projected to grow, with estimates suggesting a compound annual growth rate (CAGR) of around 8% over the next five years. As healthcare providers and patients alike recognize the benefits of these technological advancements, the compression therapy market is likely to experience a surge in demand.

### Increased Focus on Preventive Healthcare

The shift towards preventive healthcare is influencing the [compression therapy market](../../../reports/compression-therapy-market-7185) positively. As healthcare systems emphasize early intervention and management of chronic conditions, compression therapy is increasingly recognized for its role in preventing complications associated with venous disorders. This proactive approach aligns with the broader healthcare trend of reducing long-term costs associated with untreated conditions. The market is likely to benefit from initiatives aimed at educating both healthcare professionals and patients about the advantages of compression therapy. Furthermore, insurance coverage for preventive treatments is expanding, which may enhance accessibility and affordability for patients. This focus on prevention could lead to a substantial increase in the adoption of compression therapy solutions.

### Growing Demand for Non-Invasive Treatment Options

The rising preference for non-invasive treatment options is a notable driver for the compression therapy market. Patients are increasingly seeking alternatives to surgical interventions due to concerns about recovery times, complications, and costs. Compression therapy offers a viable solution that is both effective and less invasive, making it an attractive option for managing various conditions. The market is witnessing a shift as more healthcare providers recommend compression garments as first-line treatments for venous disorders. This trend is likely to continue, with a growing body of evidence supporting the efficacy of compression therapy. As patient awareness increases and the healthcare landscape evolves, the demand for non-invasive therapies, including compression therapy, is expected to rise.

### Increasing Prevalence of Chronic Venous Disorders

The rising incidence of chronic venous disorders, such as varicose veins and chronic venous insufficiency, is a primary driver for the compression therapy market. According to recent data, approximately 25 million adults in the US are affected by chronic venous diseases, leading to a growing demand for effective treatment options. Compression therapy is recognized as a non-invasive and cost-effective solution for managing these conditions. As healthcare providers increasingly recommend compression garments, the market is expected to expand significantly. The increasing prevalence of obesity and sedentary lifestyles further exacerbates these disorders, indicating a potential growth trajectory for the compression therapy market. This trend suggests that healthcare systems may need to allocate more resources towards managing venous health, thereby enhancing the market's potential.

## Future Outlook

The [Compression Therapy Market](https://www.marketresearchfuture.com/reports/compression-therapy-market-7185) is projected to grow at a 5.42% CAGR from 2025 to 2035, driven by increasing prevalence of chronic venous diseases and rising awareness of preventive healthcare.

**New opportunities:**

- Development of smart compression devices with IoT integration Expansion of telehealth services for remote patient monitoring Partnerships with healthcare providers for bundled service offerings

By 2035, the compression therapy market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Product Type: Compression Garments (Largest) vs. Compression Bandages (Fastest-Growing)

The US compression therapy market exhibits a diverse distribution of market share among its product types, with compression garments holding the largest share due to their broad application in both medical and athletic contexts. Compression hosiery and pumps also contribute significantly, while compression bandages are gaining traction, especially in acute care settings, enhancing recovery in surgical procedures.

Recent trends indicate that the market is evolving, driven by an increasing focus on preventive care and the rising prevalence of chronic conditions like venous insufficiency. Enhanced awareness regarding the benefits of compression therapy is propelling growth, particularly in the compression bandages segment, which is expected to see the fastest growth. Advances in fabric technology and product innovation are also key factors propelling the market forward.

Compression Garments (Dominant) vs. Compression Bandages (Emerging)

Compression garments serve as the dominant product category in the US compression therapy market, widely recognized for their efficacy in providing support for various medical conditions, including varicose veins and sports recovery. They are available in various designs such as sleeves, shorts, and full-body suits, catering to different consumer needs. On the other hand, compression bandages are emerging as a vital alternative, especially in hospital settings, due to their flexibility and ease of application. These bandages are often preferred for acute injury management and postoperative care. As both segments adapt to consumer demands and medical advancements, their market positions reflect a dynamic interplay between established practices and innovative solutions.

### By Application: Chronic Venous Insufficiency (Largest) vs. Lymphedema (Fastest-Growing)

In the US compression therapy market, Chronic Venous Insufficiency (CVI) currently holds the largest market share among various applications, primarily due to the increasing prevalence of venous disorders linked to aging populations and sedentary lifestyles. Following closely is Lymphedema, which is gaining traction as awareness and diagnosis improve, enabling a broader patient reach and more tailored treatments.

Growth trends in this segment reveal a significant uptick in demand for compression therapy products due to rising incidences of lifestyle-related conditions and surgical recoveries. The focus on preventive healthcare and rehabilitation has led to innovation in compression technologies, making therapies more accessible and effective. As healthcare providers emphasize comprehensive management for post-surgical care and sports injuries, compression therapy will likely continue to expand its market presence.

Chronic Venous Insufficiency: Dominant vs. Lymphedema: Emerging

Chronic Venous Insufficiency (CVI) is characterized by inadequate blood flow in the veins, often requiring long-term management through compression therapy. This segment remains dominant due to a substantial patient base and established treatment protocols. In contrast, Lymphedema, which results from lymphatic system dysfunction, is rapidly emerging as awareness increases among healthcare professionals and patients alike. Both segments exhibit unique treatment needs: CVI management often focuses on long-term compression garments, while Lymphedema may utilize specialized products for targeted care. The growth in Lymphedema treatments underscores an evolving market where faster diagnosis and innovative product offerings attract new investments and research.

### By End User: Hospitals (Largest) vs. Home Care Settings (Fastest-Growing)

In the US compression therapy market, hospitals hold the largest market share, driven by their comprehensive services and ability to cater to a wide range of medical needs. Ambulatory Surgical Centers and Rehabilitation Centers also contribute significantly but trail behind the hospital segment. Home Care Settings are gaining traction, increasingly preferred by patients opting for at-home treatments resulting in notable shifts in market preferences.

Growth trends indicate a robust increase in demand for compression therapy, particularly in home care settings, driven by factors such as the aging population and rising chronic diseases. The push towards outpatient care is further enhancing the growth of ambulatory surgical centers. The integration of advanced technologies in rehabilitation centers is also propelling their growth, making them vital players in the market.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals represent a dominant force in the compression therapy market, providing a variety of treatment options and facilities. Their extensive range of resources, skilled personnel, and ability to manage complex cases establish them as the preferred destination for patients requiring compression therapy. Conversely, Ambulatory Surgical Centers are emerging as key players, offering lower-cost alternatives with a focus on outpatient procedures. These centers are becoming increasingly popular due to their efficiency and patient-centric models, catering to a segment of the population that values convenience and timely access to treatment. The shift towards these centers is indicative of changing consumer preferences in healthcare delivery.

### By Distribution Channel: Retail Pharmacies (Largest) vs. Online Pharmacies (Fastest-Growing)

The distribution of market share among the various channels in the US compression therapy market illustrates a strong preference for retail pharmacies, which hold the largest share due to their accessibility and established trust among consumers. Retail pharmacies account for a significant portion of purchases, supported by their wide-ranging product availability and in-person consultations that enhance customer confidence in their choices. On the other hand, online pharmacies are rapidly capturing attention as more consumers shift towards the convenience of digital shopping, illustrating a notable growth trend fueled by the pandemic's acceleration of e-commerce practices.

The growth trends within this segment showcase a dynamic shift in consumer behavior, with online pharmacies emerging as the fastest-growing channel. Increased reliance on technology, the ease of browsing and purchasing from home, and the competitive pricing offered by online platforms are key drivers behind this shift. Moreover, the rise of telehealth services has further supported the growth of online pharmacies, allowing consumers to obtain prescriptions digitally, thus expanding their accessibility. As both channels compete, the landscape of distribution in the US compression therapy market continues to evolve, with an emphasis on providing convenient and efficient service.

Retail Pharmacies (Dominant) vs. Online Pharmacies (Emerging)

Retail pharmacies have long been the dominant force in the distribution of compression therapy products, characterized by their physical presence and ability to offer personalized services to customers. They benefit from established relationships with healthcare providers, ensuring that patients receive the appropriate solutions based on their specific needs. Their extensive product ranges and knowledgeable staff provide a level of trust that is crucial in this medical market. In contrast, online pharmacies are increasingly recognized as an emerging channel, appealing primarily due to their convenience and competitive pricing. They offer customers the ability to shop from the comfort of their homes, often providing a broader selection of products. As the market continues to evolve, both retail and online pharmacies are likely to play significant roles, each catering to different consumer preferences.

## Competitive Benchmarking

The compression therapy market in the US is characterized by a dynamic competitive landscape, driven by increasing awareness of chronic venous diseases and the growing prevalence of conditions requiring compression therapy. Key players such as Medi USA (US), Tactile Medical (US), and 3M (US) are strategically positioned to leverage innovation and technological advancements. Medi USA (US) focuses on enhancing product offerings through research and development, while Tactile Medical (US) emphasizes direct-to-consumer strategies to expand its market reach. 3M (US) is actively pursuing partnerships to integrate advanced materials into its compression products, thereby enhancing performance and patient comfort. Collectively, these strategies contribute to a competitive environment that is increasingly focused on innovation and customer-centric solutions. In terms of business tactics, companies are localizing manufacturing to reduce lead times and optimize supply chains, which is particularly crucial in a market that is moderately fragmented. The competitive structure allows for both established players and emerging companies to coexist, with larger firms often acquiring smaller entities to enhance their product portfolios and market presence. This consolidation trend is indicative of a market that values efficiency and responsiveness to consumer needs. In October 2025, Tactile Medical (US) announced the launch of a new telehealth platform aimed at improving patient access to compression therapy consultations. This strategic move is significant as it aligns with the growing trend of digital health solutions, potentially increasing patient engagement and adherence to therapy regimens. By integrating telehealth, Tactile Medical (US) not only enhances its service offerings but also positions itself as a leader in patient-centric care. In September 2025, Medi USA (US) unveiled a new line of eco-friendly compression garments, reflecting a commitment to sustainability. This initiative is particularly relevant as consumers increasingly prioritize environmentally responsible products. By adopting sustainable practices, Medi USA (US) not only meets market demand but also differentiates itself in a competitive landscape that is becoming more conscious of environmental impact. In August 2025, 3M (US) entered into a strategic partnership with a leading healthcare technology firm to develop AI-driven solutions for personalized compression therapy. This collaboration is poised to revolutionize the way compression therapy is prescribed and monitored, potentially leading to improved patient outcomes. The integration of AI into product development signifies a shift towards more tailored healthcare solutions, which could redefine competitive dynamics in the market. As of November 2025, current trends in the compression therapy market are heavily influenced by digitalization, sustainability, and the integration of advanced technologies such as AI. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technology integration, and supply chain reliability. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive edge.

## Report Scope

| MARKET SIZE 2024 | 819.11(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 863.51(USD Million) |
| MARKET SIZE 2035 | 1463.89(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.42% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Medi USA (US), Sigvaris (CH), BSN Medical (DE), 3M (US), Juzo (DE), Lohmann & Rauscher (DE), Tactile Medical (US), Compression Therapy (US), Venosan (CH) |
| Segments Covered | Product Type, Application, End User, Distribution Channel |
| Key Market Opportunities | Integration of smart technology in compression therapy devices enhances patient compliance and treatment outcomes. |
| Key Market Dynamics | Rising demand for innovative compression therapy solutions driven by regulatory changes and evolving consumer preferences. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of the US compression therapy market in 2024?**
A: The market valuation of the US compression therapy market was $819.11 Million in 2024.

**Q: What is the projected market valuation for the US compression therapy market by 2035?**
A: The projected market valuation for the US compression therapy market is $1463.89 Million by 2035.

**Q: What is the expected CAGR for the US compression therapy market during the forecast period 2025 - 2035?**
A: The expected CAGR for the US compression therapy market during the forecast period 2025 - 2035 is 5.42%.

**Q: Which product type segment had the highest valuation in 2024?**
A: In 2024, the compression hosiery segment had the highest valuation at $369.11 Million.

**Q: What is the valuation range for compression garments in the US compression therapy market?**
A: The valuation range for compression garments in the US compression therapy market is $200.0 Million to $360.0 Million.

**Q: Which application segment is projected to grow the most by 2035?**
A: The post-surgical recovery application segment is projected to grow the most, with a valuation range of $369.11 Million to $563.89 Million by 2035.

**Q: What was the valuation of hospitals as an end user in 2024?**
A: The valuation of hospitals as an end user in 2024 was $300.0 Million.

**Q: Which distribution channel is expected to have the highest valuation by 2035?**
A: By 2035, retail pharmacies are expected to have the highest valuation, projected between $300.0 Million and $540.0 Million.

**Q: Who are the key players in the US compression therapy market?**
A: Key players in the US compression therapy market include Medi USA, Sigvaris, BSN Medical, 3M, Juzo, Lohmann & Rauscher, Tactile Medical, Compression Therapy, and Venosan.

**Q: What is the valuation range for compression pumps in the US compression therapy market?**
A: The valuation range for compression pumps in the US compression therapy market is $100.0 Million to $180.0 Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-compression-therapy-market-18054*